PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Frost & Sullivan Recognizes Transport Pharmaceuticals Innovative Electrokinetic Drug Delivery Platform - 2007 North American Technology Innovation of the Year Award in electrokinesis-enabled drug delivery in recognition of its development of a unique platform technology
Frost & Sullivan Recognizes Transport Pharmaceuticals Innovative Electrokinetic Drug Delivery Platform

 

NewswireToday - /newswire/ - Palo Alto, CA, United States, 2007/12/10 - 2007 North American Technology Innovation of the Year Award in electrokinesis-enabled drug delivery in recognition of its development of a unique platform technology.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Frost & Sullivan has presented Transport Pharmaceuticals, Inc. with the 2007 North American Technology Innovation of the Year Award in electrokinesis-enabled drug delivery in recognition of its development of a unique platform technology that enhances the delivery of topically applied drugs and the utility of potent systematically delivered drugs.

"Founded in 1999, this privately held, venture-backed specialty pharmaceutical company based in Massachusetts is revolutionizing the treatment of dermal diseases by bringing together cutting-edge medical electronics with advanced drug formulation and material sciences to develop combination drug-device products," stated Frost & Sullivan Industry Analyst Pramodh Ishwarakrishnan.

Transport Pharmaceuticals' lead product, the SoloVir™ Electrokinetic Transdermal System (SoloVir™ ETS), represents a significant breakthrough in the treatment of herpes labialis or cold sores by enabling drug delivery via a small handheld device and a unit dose disposable medication applicator.

Using a small wireless reusable microprocessor-controlled drug delivery unit that fits onto a finger, and a pre-filled drug reservoir cartridge, this combination drug/device system allows patients to self-administer a drug for a variety of indications.

The system is capable of delivering 100 times more acyclovir (a leading topical antiviral drug) directly into the skin area than currently available treatment options, and requires only one painless, ten-minute treatment application.

"Capitalizing on electrokinetic drug delivery, the SoloVir™ ETS eliminates the concomitant problems of pain, trauma, and the risk of patient infection," says Ishwarakrishnan. "Human trials have been performed for SoloVir™ ETS and the technology has been validated in several U.S. clinical trials in over 1000 patients."

Patent applications have been filed for the SoloVir™ ETS, including the company's novel acyclovir formulation, the device and the drug cartridge. Sixty-five applications of the technology are under review and the company, to date, has been granted 13 U.S. patents and 11 international patents.

Transport Pharmaceuticals, Inc. outsources manufacturing of the drug and the device but ensures quality through its in-house engineering, regulatory and quality affairs groups who work closely with vendors to integrate their processes into Transport's quality systems. The business model provides the flexibility and the necessary cost savings of a "virtual" model and helps ensure the timely and quality performance by vendors.

The company has also had considerable success in attracting venture capital investment, a fact that positively reflects on the promise of the company's technology. It has raised a total of $36 million from highly regarded VC's, such as the Carlyle Group, Quaker Bioventures and the Hillman Company.

Each year, Frost & Sullivan's Technology Innovation of the Year Award is bestowed upon a company that has carried out new research, which has resulted in innovations that are expected to bring significant contributions to the industry in terms of adoption, change, and competitive.

posture. This Award recognizes the quality and depth of a company's research and development program as well as the vision and risk-taking that enabled it to undertake such an endeavor.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About Transport Pharmaceuticals, Inc.
Transport is a specialty pharmaceutical company revolutionizing the treatment of dermal diseases by bringing together cutting edge medical electronics, drug formulation and materials science to develop novel drug/device combination products. This unique combination of technologies can enhance the delivery of topically applied drugs and the utility of potent systemically delivered drugs whose uses are limited by bio-availability, toxicity or side effect concerns.

About Frost & Sullivan
Frost & Sullivan, the Growth Consulting Company, partners with clients to accelerate their growth. The company's Growth Partnership Services, Growth Consulting and Career Best Practices empower clients to create a growth focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Metropolitan Area

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Frost & Sullivan Recognizes Transport Pharmaceuticals Innovative Electrokinetic Drug Delivery Platform

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Melina Trevino 
210.247.2440 melina.trevino[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Medical Services/Equipment Most Recent Related Newswires:

Frost & Sullivan Recognizes Ventec Life Systems for New Product Innovation - Game-changing, Modular Respiratory System, VOCSN
BD Expands Genomics Portfolio with New Single Cell Platform for RNA Expression Analysis
GE Healthcare Advances the Delivery of Cell Therapies with New Thawing Technology
Ansell Limited Announces the Closing of the Sale of its Sexual Wellness Business
PQ Bypass Earns Frost & Sullivan’s European Technology Innovation Award for its Proprietary DETOUR System for Percutaneous Bypass
Curaçao EMS Uses ZOLL Autopulse to Save Tourist in Sudden Cardiac Arrest
ZOLL to Showcase Expanded Portfolio of AEDs at Caravan Salon 2017
MDxHealth Announces Service Agreement with Kaiser Southern California Permanente Medical Group
Frost & Sullivan Lauds CytoSorbents for Leading the Critical Care Immunotherapy Segment with its Novel Blood Purification Solution, CytoSorb®
MVZ Dr. Stein & Kollegen First German Medical Laboratory to Offer the SelectMDx for Prostate Cancer Test
Datalogic Announces New Healthcare Memor X3 HC Mobile Computer
Neuronix Ltd Announces the First Group of Mild to Moderate Alzheimer Patients to be Successfully Treated by The NeuroAD™ Therapy System
SelectMDx to be Distributed Across Middle East by IPS Genomix
GE Healthcare Partners with Oritain to Introduce Independent Test to Confirm Country of Origin of Fetal Bovine Serum
Saebo, Inc. Awarded Patent for Low-Profile Stroke Recovery Glove

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  NAKIVO, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)